BL Pharmtech Corp. (KOSDAQ:065170)
South Korea · Delayed Price · Currency is KRW 1,901.00
-24.00 (-1.25%)
At close: Oct 23, 2026
BL Pharmtech Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,090 | 6,506 | 8,806 | 24,525 | 22,523 | 84,440 |
Revenue Growth | -64.20% | -26.12% | -64.10% | 8.89% | -73.33% | 28.54% |
Gross Profit Gross Profit Growth | 1,146 | 3,692 | 5,921 | 13,561 | 12,722 | 21,073 |
Operating Income Operating Income Growth | -1,205 | -2,032 | -4,345 | -7,119 | -4,789 | -3,595 |
Net Income Net Income Growth | -16,003 | -16,778 | -5,706 | -148.85 | -13,903 | -20,211 |
Earnings Per Share EPS Growth | -598.76 | -629.00 | -214.00 | -5.58 | -520.90 | -767.32 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Other Growth | 1,553 | 2,046 | 8,116 | 8,359 | 14,453 |
Health Functional Food Health Functional Food Growth | 5,015 | 6,841 | 16,524 | 14,396 | 78,743 |
Adjust and Remove Adjust and Remove Growth | -61.79 | -81.09 | -114.89 | -231.76 | -8,755 |
Total Total Growth | 6,506 | 8,806 | 24,525 | 22,523 | 84,440 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,789 | 7,151 | 3,864 | 13,207 | 5,524 | 22,752 |
Total Debt Total Debt Growth | 3,451 | 5,042 | 6,100 | 4,262 | 42,706 | 41,894 |
Net Cash (Debt) Net Cash Growth | 2,338 | 2,110 | -2,236 | 8,945 | -37,182 | -19,142 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 87.45 | 79.07 | -83.80 | 335.15 | -1393.08 | -726.73 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -1,343 | -283.76 | -3,037 | 7,992 | -10,998 | 3,097 |
Capital Expenditures CapEx Growth | - | - | -1,166 | -312.07 | -1,708 | -587.15 |
Free Cash Flow Free Cash Flow Growth | -1,343 | -283.76 | -4,203 | 7,680 | -12,706 | 2,510 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.09% | 56.74% | 67.24% | 55.30% | 56.48% | 24.96% |
Operating Margin | -39.01% | -31.24% | -49.34% | -29.03% | -21.26% | -4.26% |
Pretax Margin | -517.15% | -257.94% | -65.48% | -56.50% | -62.48% | -24.36% |
Profit Margin | -517.91% | -257.89% | -64.81% | -0.61% | -61.73% | -23.94% |
FCF Margin | -43.46% | -4.36% | -47.74% | 31.31% | -56.41% | 2.97% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | - | - | - | 5.85 | - | 46.44 |
PS Ratio | 17.17 | 2.25 | 2.36 | 1.83 | 2.47 | 1.38 |